STAT3 and neoplasm: For instance, phosphosite‐resolved signalling may distinguish immune‐inflamed versus stromal/mesenchymal‐dominant states, or separate tumours with STAT3/TGF‐β–driven EMT from those dominated by ECM remodelling and macrophage programs.